Syncona leads $80 mln round for gene therapy firm Autolus – Reuters
|
Syncona leads $80 mln round for gene therapy firm Autolus
Reuters LONDON, Sept 26 (Reuters) – Syncona has led a $80 million investment in Autolus, a company developing gene therapies to treat cancer, the healthcare investment group said on Tuesday. Gene-modifying immunotherapy is a new type of cancer treatment … |
